Chandra Ohri

2.0k total citations
17 papers, 724 citations indexed

About

Chandra Ohri is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chandra Ohri has authored 17 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chandra Ohri's work include Fibroblast Growth Factor Research (5 papers), Asthma and respiratory diseases (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Chandra Ohri is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), Asthma and respiratory diseases (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Chandra Ohri collaborates with scholars based in United Kingdom, Canada and Sweden. Chandra Ohri's co-authors include Peter Bradding, David Waller, A Shikotra, Aarti Shikotra, Ruth H. Green, Joseph R. Arron, Alexander R. Abbas, David F. Choy, Janet Jackman and Emma Doran and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Chandra Ohri

16 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chandra Ohri United Kingdom 9 434 257 195 158 137 17 724
S. Doi Japan 14 264 0.6× 336 1.3× 71 0.4× 152 1.0× 101 0.7× 18 639
Violeta Régnier Galvão Brazil 14 257 0.6× 125 0.5× 182 0.9× 53 0.3× 72 0.5× 22 729
Jan Wierecky Germany 7 286 0.7× 105 0.4× 176 0.9× 39 0.2× 179 1.3× 15 564
Emmanuelle Henry Belgium 7 537 1.2× 123 0.5× 167 0.9× 115 0.7× 158 1.2× 7 700
Taro Okayama Japan 11 101 0.2× 169 0.7× 114 0.6× 59 0.4× 72 0.5× 24 490
Christina H. Swasey United States 9 249 0.6× 258 1.0× 31 0.2× 88 0.6× 54 0.4× 10 464
Nobutaka Edakuni Japan 14 95 0.2× 286 1.1× 84 0.4× 336 2.1× 115 0.8× 46 573
Mary Kämpe Sweden 11 94 0.2× 445 1.7× 28 0.1× 392 2.5× 71 0.5× 17 647
Luís Felipe Ensina Brazil 15 198 0.5× 96 0.4× 62 0.3× 37 0.2× 49 0.4× 72 694
Tim Oates United Kingdom 6 86 0.2× 559 2.2× 56 0.3× 511 3.2× 150 1.1× 8 808

Countries citing papers authored by Chandra Ohri

Since Specialization
Citations

This map shows the geographic impact of Chandra Ohri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Ohri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Ohri more than expected).

Fields of papers citing papers by Chandra Ohri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra Ohri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Ohri. The network helps show where Chandra Ohri may publish in the future.

Co-authorship network of co-authors of Chandra Ohri

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra Ohri. A scholar is included among the top collaborators of Chandra Ohri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra Ohri. Chandra Ohri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Howick, Jeremy, et al.. (2024). Towards an empathic hidden curriculum in medical school: A roadmap. Journal of Evaluation in Clinical Practice. 30(4). 525–532. 10 indexed citations
2.
Diver, Sarah, et al.. (2021). The value of healthcare worker support strategies to enhance wellbeing and optimise patient care. Future Healthcare Journal. 8(1). e60–e66. 8 indexed citations
3.
Shikotra, Aarti, David F. Choy, Salman Siddiqui, et al.. (2017). A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma. The Journal of Immunology. 198(8). 3307–3317. 24 indexed citations
4.
Shikotra, A, et al.. (2016). Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer. Scientific Reports. 6(1). 38352–38352. 46 indexed citations
5.
Shikotra, Aarti, David F. Choy, Salman Siddiqui, et al.. (2015). CEACAM6-high airway neutrophils and epithelial cells are a feature of severe asthma. PA910–PA910. 1 indexed citations
6.
Choy, David F., Aarti Shikotra, Salman Siddiqui, et al.. (2014). Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma. European Respiratory Journal. 44(Suppl 58). P3868–P3868. 4 indexed citations
7.
Gonem, Sherif, Amisha Singapuri, Per Gustafsson, et al.. (2014). Lung clearance index in adults with non-cystic fibrosis bronchiectasis. Respiratory Research. 15(1). 59–59. 32 indexed citations
8.
Ohri, Chandra, et al.. (2014). 43 Experience with fosfomycin: clinical outcomes at an adult UK CF centre. Journal of Cystic Fibrosis. 13. S57–S57. 1 indexed citations
9.
Nash, E.F., Chandra Ohri, Anne L. Stephenson, & Peter R. Durie. (2013). Abdominal pain in adults with cystic fibrosis. European Journal of Gastroenterology & Hepatology. 26(2). 129–136. 8 indexed citations
10.
Shikotra, A, David F. Choy, Chandra Ohri, et al.. (2012). Increased expression of immunoreactive thymic stromal lymphopoetin in severe asthma. Journal of Allergy and Clinical Immunology.
11.
Shikotra, Aarti, David F. Choy, Chandra Ohri, et al.. (2011). Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. Journal of Allergy and Clinical Immunology. 129(1). 104–111.e9. 257 indexed citations
12.
Ohri, Chandra, Aarti Shikotra, Ruth H. Green, David Waller, & Peter Bradding. (2011). The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC. PLoS ONE. 6(7). e21874–e21874. 39 indexed citations
13.
Ohri, Chandra, Aarti Shikotra, Ruth H. Green, David Waller, & Peter Bradding. (2011). Correction: The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC. PLoS ONE. 6(11). 2 indexed citations
14.
Ohri, Chandra, Aarti Shikotra, Ruth H. Green, David Waller, & Peter Bradding. (2010). Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. BMC Cancer. 10(1). 172–172. 34 indexed citations
15.
Ohri, Chandra, Aarti Shikotra, Ruth H. Green, David Waller, & Peter Bradding. (2010). Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer. BMC Cancer. 10(1). 323–323. 23 indexed citations
16.
Ohri, Chandra, et al.. (2008). Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. European Respiratory Journal. 33(1). 118–126. 234 indexed citations
17.
Ohri, Chandra, A Shikotra, David Waller, & Peter Bradding. (2008). Macrophage phenotypes and their expression in non-small cell lung cancer. Journal of Clinical Oncology. 26(15_suppl). 22132–22132. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026